Mesa Biotech received Emergency Use Authorization from FDA for 30 minute point of Care molecular COVID-19 test
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Mar. 24, 2020, BioSig Technologies announced that its majority-owned subsidiary NeuroClear Technologies, acquired the rights to develop a…
On Mar. 24, 2020, Nebraska Medicine has developed a safe and effective method to decontaminate single-use personal protective…
On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid…
On Mar. 24, 2020, BioReference Laboratories, an OPKO Health company, announced a collaboration with the City of Miami…
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…
On Mar. 24, 2020, Emerald Organic Products and Todos Medical announced the creation of Corona Diagnostics, a joint…
On Mar. 24, 2020, T2 Biosystems announced it had entered into a worldwide licensing agreement for a rapid…
On Mar. 24, 2020, Ology Bioservices and Inovio Pharma announced the Department of Defense (DOD) has awarded Ology…
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
On Mar. 24, 2020, Windtree Therapeutics announced it will study its proprietary KL4 surfactant to potentially mitigate the…
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
On Mar. 23, 2020, the UK Government announced funding of £20 million to support clinicians and scientists in…
On Mar. 23, 2020, the Amgen Foundation announced an initial commitment of up to $12.5 million to support…
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
On Mar. 23, 2020, Drug Innovation Ventures at Emory (DRIVE), and Ridgeback Biotherapeutics announced a collaboration to rapidly…
On Mar. 23, 2020, Acura Pharmaceuticals announced that Abuse Deterrent Pharma, its licensee of LTX-03 (Hydrocodone Bitartrate and…
On Mar. 23, 2020, Harvard Bioscience announced that it had launched an innovative technology – known as Accumulated…
On Mar. 23, 2020, Covetrus reported that the company saw strong demand in its prescription management and online…
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
On Mar. 23, 2020, Heat Biologics announced that it was collaborating with the University of Miami to develop…
On Mar. 23, 2020, LabCorp announced that it was exploring all options to prioritize COVID-19 testing for the…
On Mar. 23, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the City of Detroit…
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…
On Mar. 23, 2020, an expert team of researchers and clinicians in microbiology, virology, pathology, molecular science, and…
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
On Mar. 23, 2020, Resverlogix announced a bioRxiv publication that has shown apabetalone to inhibit specialized proteins –…
On Mar. 23, 2020, researchers from the University of Oxford announced they have launched a new clinical trial…
On Mar. 22, 2020, Royal Philips announced that it is increasing the production of certain critical care products and…